CH Biotech R&D Co., Ltd. (TPE:6534)
94.50
+0.50 (0.53%)
Oct 8, 2026, 1:30 PM CST
| Market Cap | 9.53B -19.4% |
| Revenue (ttm) | 1.87B +11.3% |
| Net Income | 604.70M +66.0% |
| EPS | 5.88 +66.6% |
| Shares Out | 100.80M |
| PE Ratio | 16.08 |
| Forward PE | n/a |
| Dividend | 5.31 (5.62%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 180,070 |
| Open | 94.50 |
| Previous Close | 94.00 |
| Day's Range | 94.50 - 95.40 |
| 52-Week Range | 77.60 - 116.00 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 5, 2026 |